Sango-an, Leonardo D.

HRN: 22-28-08  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2022
CEFTRIAXONE 1G (VIAL)
11/30/2022
12/06/2022
IV
2g
Q24H
Community Acquired Pneumonia - Moderate Risk
Waiting Final Action 
12/01/2022
CO-AMOXICLAV 625MG (TAB)
12/01/2022
12/07/2022
PO
625mg
BID
Infected Tophi
Waiting Final Action 
12/01/2022
CLINDAMYCIN 300MG (CAP)
12/01/2022
12/07/2022
PO
300mg
QID
Infected Tophi
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: